Fred Conrad Koch Lifetime Achievement Award Mitchell A. Lazar, MD, PhD Lazar is the Willard and Rhoda Ware Professor in Diabetes and Metabolic Diseases at the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, and the founding director of the university’s Institute for Diabetes, Obesity, and Metabolism. He is an endocrinologist and...
Protocols for treating this common cancer complication are provided in latest Clinical Practice Guideline Experts provide the first framework for treating a common and life-threatening metabolic complication of cancer known as hypercalcemia of malignancy in the Endocrine Society’s new Clinical Practice Guideline. The guideline, titled “Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society...
Endocrine News talks with Ghada El-Hajj Fuleihan, MD, MPH, and Matthew T. Drake, MD, PhD, co–chairs of the guideline development panel that created the latest Endocrine Society Clinical Practice Guideline on treating hypercalcemia of malignancy. Hypercalcemia of malignancy (HCM) is the most common metabolic complication of cancer, but its incidence may be declining due to...
People with diabetes are benefiting from advances in medications and technologies to lower their risk of hypoglycemia, according to a Clinical Practice Guideline issued today by the Endocrine Society. The guideline, titled “Management of Individuals with Diabetes at High Risk for Hypoglycemia: An Endocrine Society Clinical Practice Guideline,” was published online and will appear in the March 2023 print...
Endocrine News talks with Anthony L. McCall, MD, PhD, FACP and David C. Lieb, MD, FACP, co–chairs of the guideline development panel that created the latest Endocrine Society Clinical Practice Guideline on managing hypoglycemia in people with diabetes. In the last decade or so, the amount of progress made in treating people with hypoglycemia has...
Anti-science rule threatens to harm transgender and gender-diverse minors; sets dangerous precedent for all health care decisions The Endocrine Society rebukes the Florida Board of Medicine’s decision to ban gender-affirming care for transgender and gender-diverse teenagers. We call on the Florida Board of Medicine to reverse the ban and allow physicians to provide evidence-based care and protect...
To commemorate the 40th anniversary of the Korean Endocrine Society (KES), Endocrine News is sharing a history of a vital sister organization to the Endocrine Society. First founded as a discussion group, the KES has grown into an internationally recognized endocrinology association that has impacted patient care and scientific research around the world. The Korean...
In May, the Endocrine Society launched its latest Special Interest Group (SIG) focused on oncoendocrinology. Even though there is a SIG devoted to endocrine cancers, this new SIG will focus on endocrine and metabolic consequences of non-endocrine cancers and their treatments. In 2019, the Endocrine Society launched Special Interest Groups (SIGs) with the aim of...
To commemorate the 40th anniversary of the Korean Endocrine Society (KES), Endocrine News is sharing a history of a vital sister organization to the Endocrine Society. First founded as a discussion group, the KES has grown into an internationally recognized endocrinology association that has impacted patient care and scientific research around the world. The Korean...
In May, the Endocrine Society launched its latest Special Interest Group (SIG) focused on oncoendocrinology. Even though there is a SIG devoted to endocrine cancers, this new SIG will focus on endocrine and metabolic consequences of non-endocrine cancers and their treatments. In 2019, the Endocrine Society launched Special Interest Groups (SIGs) with the aim of...
